acridines has been researched along with Pancreatic Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Billadeau, DD; Ferguson, DM; Goodell, JR; Hiasa, H; Kaur, H; Luchini, DN; Oppegard, LM; Ougolkov, AV; Schoon, RA | 1 |
| Baker, L; Corbett, T; Foster, B; Horwitz, J; Kempff, M; Palomino, E; Wiegand, R | 1 |
| Heilbrun, LK; Kraut, M; LoRusso, P; Philip, PA; Shields, AF; Vaitkevicius, V; Zalupski, MM | 1 |
| Biernat, L; Capps, D; Corbett, TH; Dan, ME; Leopold, WR; LoRusso, P; Polin, L; Werbel, LM; Wozniak, AJ | 1 |
1 trial(s) available for acridines and Pancreatic Neoplasms
| Article | Year |
|---|---|
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Middle Aged; Neutropenia; Pancreatic Neoplasms; Pyrazoles; Thrombocytopenia; Treatment Outcome | 1998 |
3 other study(ies) available for acridines and Pancreatic Neoplasms
| Article | Year |
|---|---|
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II.
Topics: Acridines; Animals; Antineoplastic Agents; Biocatalysis; Cell Line, Tumor; Cell Proliferation; DNA; DNA Topoisomerases, Type II; Enzyme Inhibitors; Female; Humans; Intercalating Agents; Mice; Pancreatic Neoplasms; Topoisomerase II Inhibitors; Transplantation, Heterologous | 2009 |
Identification and antitumor activity of a reduction product in the murine metabolism of pyrazoloacridine (NSC-366140).
Topics: Acridines; Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Feces; Male; Mass Spectrometry; Mice; Neoplasms, Experimental; Oxidation-Reduction; Pancreatic Neoplasms; Pyrazoles; Tumor Cells, Cultured | 1996 |
Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.
Topics: Acridines; Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Intraductal, Noninfiltrating; Cell Survival; Colonic Neoplasms; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Pancreatic Neoplasms; Pyrazoles; Tumor Cells, Cultured | 1990 |